Amgen Shares (Diluted) increased by 0.2% to 542M in Q3 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 542M to 542M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to basic shares indicates a higher reliance on equity-based compensation or convertible debt financing.
Weighted-average shares outstanding (diluted) includes the total number of basic common shares plus all additional share...
Commonly compared against basic shares to determine the 'dilution overhang' present in a company's capital structure.
is_weighted_shares_diluted| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 576M | 570M | 551M | 537M | 538M | 538M | 537M | 538M | 536M | 541M | 542M | 3M | 541M | 542M |
| QoQ Change | — | -1.0% | -3.3% | -2.5% | +0.2% | +0.0% | -0.2% | +0.2% | -0.4% | +0.9% | +0.2% | -99.4% | >999% | +0.2% |
| YoY Change | — | — | — | -6.8% | -5.6% | -2.4% | +0.0% | +0.0% | -0.4% | +0.7% | +0.7% | -99.4% | +0.0% | +0.0% |